Cooper Companies (COO) Following JANA Pressure Has Undervaluation Back In Focus
Cooper Companies (COO) is under fresh scrutiny after activist investor JANA Partners urged the board to replace top leadership, rethink incentives, and consider selling CooperVision and its fertility and medical device operations.
Cooper Companies has been under pressure for some time, with the share price down 30.18% year to date and the 1-year total shareholder return declining 17.40%. The recent activist campaign, the FTSE All-World index removal, and the new Vision Centre opening have pushed that existing momentum and risk debate into sharper focus.
Compare how Cooper Companies stacks up against other under-pressure healthcare players by scanning our hand picked list of 32 high quality undervalued stocks.
The slide in Cooper Companies appears tied to both questions about execution and a reset in market mood. To sort that out, it helps to compare the current share price with the underlying earnings power.
Most Popular Narrative: 16% Undervalued
On Simply Wall St, the most followed narrative for Cooper Companies points to a fair value of $67.43 against a last close of $56.63. This frames the recent selloff as a valuation gap rather than a verdict on the business model.
Free cash flow is poised to inflect higher as a multi-year capital expenditure cycle winds down following the ramp-up of MyDAY capacity, with management guiding for approximately $2 billion in free cash flow over the next three years. This improved cash generation, tied to strong cost discipline and revenue momentum, will further benefit shareholders via debt reduction and share repurchases.
See why 17 investors see Cooper Companies as 16% undervalued.
Result: Fair Value of $67.43 (UNDERVALUED)
Still, the bullish Cooper Companies narrative runs into real friction if the Clariti to MyDAY transition drags on, or if fertility and Paragard demand stay weak.
Find out about the key risks to this Cooper Companies narrative.
Next Steps
If the debate around Cooper Companies feels split, use that as your cue to move fast. Test the numbers yourself and pressure test the upside, then weigh those findings against the 4 key rewards.
Looking for more Cooper Companies style ideas?
If the Cooper Companies story has you thinking harder about where you put your next dollar, do not stop here. Use the Simply Wall St screener to keep surfacing fresh opportunities that fit your approach and risk comfort.
- Hunt for quality at a discount by scanning our hand picked list of 32 high quality undervalued stocks.
- Prioritise resilience and sleep better at night by reviewing a 32 resilient stocks with low risk scores that filters for sturdier balance sheets and steadier business profiles.
- Spot under-the-radar potential by checking a 17 high quality undiscovered gems that highlights companies with strong fundamentals that fewer investors are watching.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com